<TABLE>
Approach            Description                  Method    of price determination
Other  measures     Efficient dispensing         1.   Determine  the  most cost-efficient combination   of vial sizes for injectable
to ensure                                             medicines  to minimize  wastage
efficiencies
                    Enhanced   competition       1.   Determine  pricing, prescribing and  dispensing  rules for generic and biosimilar
                                                      products
                    Prior authorization          1.   Selection of medicines  for which authorization  is required prior to dispensing
                    Regular  review of benefit   1.   Selection of medicines  for review according  to certain criteria (e.g. therapeutic
                    list                              value)
                                                 2.   Retain, amend   or delist medicines according  to review findings
                    Tax reduction  or            1.   Assess the appropriateness   of the level of tariffs and taxes related to the supply of
                    exemption                         medicines
                                                 2.   Apply tax reduction  or exemption   and ensure  savings  are transferred to
                                                      consumers
                    Pooled  procurement          1.   Seek alignment   in the goals for arranging pooled  procurement
                                                 2.   Combine   financial and non-financial resources  across  various purchasing
                                                      authorities to create a single entity for purchasing health products
                                                 3.   Seek to lower  prices of medicines  and stability of supply through economies    of
                                                      scale and stronger  negotiating  power
                                                 4.   Monitor  the progress  of the arrangement   against the goals  and make
                                                      modification accordingly
</TABLE>
<UNSPECIFIED>
                                                                                                                                             Consideration
                                                                                                                                             •   Calculation algorithm  in the
                                                                                                                                                 dispensing  software
                                                                                                                                             •   Collection of data
                                                                                                                                             •   Acceptance   of policies by
                                                                                                                                                 clinicians and patients
                                                                                                                                             •   Clarity of objectives
                                                                                                                                             •   Ease  of administration
                                                                                                                                             •   Capacity  for undertaking  reviews
                                                                                                                                             •   Financial impacts  to existing
                                                                                                                                                 patients upon  changes   to listing
                                                                                                                                                 criteria
                                                                                                                                             •   Changes   in utilization of
                                                                                                                                                 medicines  remaining  on  the
                                                                                                                                                 benefit list due to substitution
                                                                                                                                                 effect
                                                                                                                                             •   Impacts  on tax revenues  and
                                                                                                                                                 medicine  prices
                                                                                                                                             •   Harmonization   of legal,
                                                                                                                                                 regulatory  and policy
                                                                                                                                                 requirements   and processes
51
</UNSPECIFIED>
<PAGE_BREAK>
